Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study of RSLV-132 in Females With Sjögren's Disease
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Resolve Therapeutics
- Target Recruit Count
- 106
- Registration Number
- NCT06440525
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸Resolve Clinical Site, San Antonio, Texas, United States
🇺🇸Evolution Research Center, Hialeah, Florida, United States
Phase 2 Study of RSLV-132 in Subjects With Long COVID
- Conditions
- Post-acute Corona Virus 19 (COVID-19) (Long COVID)
- Interventions
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Resolve Therapeutics
- Target Recruit Count
- 112
- Registration Number
- NCT04944121
- Locations
- 🇺🇸
Resolve Clinical Center, Seattle, Washington, United States
A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome
- First Posted Date
- 2017-08-14
- Last Posted Date
- 2021-04-02
- Lead Sponsor
- Resolve Therapeutics
- Target Recruit Count
- 28
- Registration Number
- NCT03247686
- Locations
- 🇬🇧
University Hospitals Birmingham, Birmingham, Edgbaston, United Kingdom
🇬🇧Newcastle upon Tyne Hospitals, Newcastle upon Tyne, Gosforth, United Kingdom
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
- First Posted Date
- 2016-01-21
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Resolve Therapeutics
- Target Recruit Count
- 64
- Registration Number
- NCT02660944
- Locations
- 🇺🇸
TriWest Research Associates, El Cajon, California, United States
🇺🇸University of California San Diego, La Jolla, California, United States
🇺🇸Valerius Research Center, Los Alamitos, California, United States
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
- Conditions
- Systemic Lupus Erythematosus
- First Posted Date
- 2014-07-18
- Last Posted Date
- 2015-12-09
- Lead Sponsor
- Resolve Therapeutics
- Target Recruit Count
- 32
- Registration Number
- NCT02194400
- Locations
- 🇺🇸
Clinical Research of West Florida, Clearwater, Florida, United States
🇺🇸West Michigan Rheumatology, Grand Rapids, Michigan, United States
🇺🇸Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States